Medicare-For-Hmmm: A Year Of House Hearings Show Democratic Disunity
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.
You may also be interested in...
The Democratic party has been advocating for Medicare drug price negotiation authority in the US for almost two decades. The coming year may see it finally happen – or it might mean the issue is gone for good.
NASEM is expected to issue a highly anticipated report in early 2021 on solutions to address Rx vial drug wastage.
The Democratic Primary focused heavily on the idea of ‘Medicare for All,’ but the emergence of former Vice President Biden as the party standard bearer – and the overwhelming impact of the COVID-19 outbreak – suggests a very different theme for the national campaign.